Psychedelic Science

Total Page:16

File Type:pdf, Size:1020Kb

Psychedelic Science Psychedelic Science Curse or salvation? We acknowledge the tradi1onal custodians of the land on which we meet today and pay respect to Elders past, present and emerging. We also extend that respect to other Aboriginal and/or Torres Strait Islanders who are joining us here today. David R Horton, creator, © Aboriginal Studies Press, AIATSIS and Auslig/ Sinclair, Knight, Merz, 1996. View an interac1ve version of the AIATSIS map www.abc.net.au/indigenous/map/ Header Artwork produced for Queensland Health by Gilimbaa Psychedelic Ancient Greek words psychē (ψυχή, "soul") and dēloun (δηλοῦν, "to make visible, to reveal"), translating to “soul- or mind-revealing or –manifesting” Synonyms: "hallucinogen", "psychotomimetic" "entheogen", (entheos “God/divine within”) Hofmann first synthesized LSD on 16 November 1938 with intention to obtain a respiratory and circulatory stimulant. He was working for Sandoz Laboratories in Basel, Switzerland. On 16 April 1943 Hofmann decided to re-examine it. While re-synthesizing LSD, he accidentally touched his hand to his mouth, nose or possibly eye, accidentally ingesting a small amount and discovered its powerful effects. Albert Hofmann (1906 –2008) “... affected by a remarkable restlessness, combined with a slight dizziness. At home I lay down and sank into a not unpleasant intoxicated-like condition, characterized by an extremely stimulated imagination. In a dreamlike state, with eyes closed (I found the daylight to be unpleasantly glaring), I perceived an uninterrupted stream of fantastic pictures, extraordinary shapes with intense, kaleidoscopic play of colors. After some two hours this condition faded away.” Hofmann was active and continued his research until the last days of his life. He was due to speak at the World Psychedelic Forum from 21 to 24 March 2008 but was forced to cancel because of bad health. It was confirmed by a close co-worker that he was microdosing LSD for at least the last two decades of his life. Albert Hofmann in 2006 Between 1953 and 1973, the US federal government spent four million dollars to fund a hundred and sixteen studies of LSD, involving more than seventeen hundred subjects. (These figures don’t include classified research.) By the mid-nineteen-sixties, LSD had escaped from the laboratory and swept through the counterculture. In 1970, Richard Nixon signed the Controlled Substances Act and put most psychedelics on Schedule 1, prohibiting their use for any purpose. Research soon came to a halt, and what had been learned was all but erased from the field of psychiatry. The research projects that were shut down in the late 1960’s are being replicated and furthered by institutes including Johns Hopkins, NYU, UCLA, UNM, University of Zurich and Imperial College, London and others around the world. So far there have been positive results for treating: nicotine addiction, alcoholism, depression and end-of-life anxiety and PTSD. The studies are not funded by traditional institutions, but by non- profit organisations: •MAPS (Multidisciplinary Association of Psychedelic Studies), •The Beckley Foundation and •Heffter Research Institute "A pharma company needs to figure out how to make an obscene profit - that's what gets their attention. The problem is that these drugs are not addicting and you don't need to take them very often," (James Fadiman) Psychedelic substances Serotonergic or classical psychedelics “tryptamines” (predominantly 5-HT2A receptor agonists): intense feelings of love, spirituality, “connectedness”, “oneness” with one’s surroundings, euphoria, altered visual and auditory sensory perceptions LSD, LSA, psilocybin, DMT, ibogaine (a “complex tryptamine”, an NDMA receptor antagonist, a K-opioid receptor agonist and 5HT2A receptor agonist, resulting in dissociative effects as well) Empathogen-entactogens ”phentelamines” (serotonin releasers and 5HT2A agonists): (feelings of openness, euphoria, empathy, love, heightened self-awareness, and by mild audio and visual distortions, an overall enhancement of sensory experience) MDMA, MDEA, MDA, mescaline, mephedrone, 2C-B. Dissociatives (NMDA antagonists) (cause more intense de-realisation and de-personalisation) ketamine Atypical: Salvia divinorum, salvinorin A (a K-opioid receptor agonist) Effects are blocked by ketanserin (5HT2 receptor antagonist) ketamine Salvinorin A Morphine The DMN “default mode network” • Regions: the posterior cingulate cortex; the medial prefrontal cortex; the lateral inferior parietal cortex • represents the anatomical basis of our sense of self, our experience of having an identity or self, and our capacity for introspection. • This network has undergone significant evolutionary expansion. • Significant ontogenetic development, from infancy to adulthood • More metabolically active then elsewhere in the brain • It serves as an important convergence zone or “connector hub” in the cortex. • Activated during high-level thinking, such as predicting the future, making personal, social and moral judgments, and contemplating the past. • Some assumption that the evolutionary development of the DMN is the biological basis for our psychological sense of “self” or “ego.” • Overactive in depression and anxiety states The TPN “task-positive network” • Regions: the dorso-lateral parietal cortex; anterior cingulate and posterior parietal cortex • Active when we attend to things in the external world (the “other”) • It is in gear when we have externally focused attention, when we get wrapped up in getting something done and relatively forget about ourselves in the process DMN and TPN • The two modes of consciousness/networks do not, in ordinary waking consciousness, become activated simultaneously. • The two networks exist side-by-side and in a somewhat competitive relationship • Each becoming active when the need arises • They alternate with extraordinary rapidity. • They provide an alternative way we view human consciousness compare to left-right brain theory Default Mode Network Effects of psilocybin on DMN and TPN • Significantly decreased activity in DMN • Competitive activity breaks down between DMN and TPN • The two networks work as “one” Magnetic resonance imaging (MRI) images of the brains of 22 regular users of ayahuasca (a preparation whose active principle is the psychedelic 5HT2A agonist N,N- dimethyltryptamine (DMT)) and 22 controls matched for age, sex, years of education, verbal IQ and fluid IQ. Ayahuasca users showed significant CT differences in midline structures of the brain, with thinning in the posterior cingulate cortex (PCC), a key node of the default mode network. CT values in the PCC were inversely correlated with the intensity and duration of prior use of ayahuasca and with scores on self-transcendence, a personality trait measuring religiousness, transpersonal feelings and spirituality. The study was conducted within the framework of the Beckley/Sant Pau Research Programme and in collaboration with the Spanish National Research Council. In the study participated the following researchers from the Spanish National Research Council (CSIC). They found that harmine and tetrahydroharmine, the alkaloids present in highest amounts in ayahuasca, stimulate the growth and maturation of neurons and promote their birth from the stem cells. Amanda Feilding and David Nutt, co-directors of the Beckley/Imperial Research Programme Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study About the Study This landmark study provides the first clinical evidence that psilocybin might help in the treatment of depression. We gave oral psilocybin to 12 patients with treatment-resistant depression (meaning they had tried at least 2 other treatment methods and none had worked). The average length of depression was over 18 years, and severity ranged from moderate to severe. Participants received 2 doses (10 and 25mg) 7 days apart, accompanied by psychological support before, during, and after each session. Following both sessions, all participants showed improvement in depressive symptoms. On standard measures of depression severity, 67% scored at levels considered ‘in remission’ (depression-free) 1 week after the treatment, and 42% were still in remission 3 months post-treatment. Psilocybin in the Treatment of Depression. As a direct result of our previous studies examining the effects of psilocybin on the brain, the UK Medical Research Council awarded a substantial grant to the Beckley / Imperial Research Programme for a ground- breaking Phase I pilot study examining psilocybin as an aid to psychotherapy in the treatment of depression. One dose of psilocybin outperformed sustained courses of both medication and psychotherapy, at 2 weeks and 3 months after the dose - © R. Carhart-Harris, 2016 Connectivity within the brain, before (top) and after (bottom) a dose of LSD- © R. Carhart-Harris, 2016. • We’re talking about people suffering from anxiety and depression. The Default Mode Network is generally overactive in people with those disorders and Psilocybin has been shown to turn off the DMN and allow the brain to behave in ways never seen before. But we still know very little for certain. Isn’t that terrifying? • “The point is we don’t know about it because no one has done it before. It’s quite fascinating. Getting some of this stuff published has been quite difficult. A lot of scientists would prefer if this whole thing went away. It raises challenges to philosophies and theories of science. It is like Einstein. We had a nice theory of physics and
Recommended publications
  • Psychoactive Substances and Transpersonal States
    TRANSPERSONAL PSYCHOLOGY RESEARCH REVIEW: PSYCHOACTIVE SUBSTANCES AND TRANSPERSONAL STATES David Lukoff San Francisco, California Robert Zanger Los Angeles, California Francis Lu San Francisco, California This "Research Review" covers recent trends in researching psychoactive substances and trans personal states of conscious­ ness during the past ten years. In keeping with the stated goals of this section of the Journal to promote research in transpersonal psychology, the focus is on the methods and trends designs which are being employed in investigations rather than during the findings on this topic. However, some recently published the books and monographs provide good summaries of the recent last findings relevant to understanding psychoactive substances ten (Cohen & Krippner, 1985b; Dobkin de Rios, 1984;Dobkin de years Rios & Winkelman, 1989b; Ratsch, 1990; Reidlinger, 1990). Because researching psychoactive substances is most broadly a cross-disciplinary venture, only a small portion of the research reviewed below was conducted by persons who consider The authors wish to acknowledge the assistance of Bruce Flath, head librarian at the California Institute of Integral Studies, San Francisco in conducting the computer bibliographic searches used in preparation of this article. The authors also wish to thank Marlene Dobkin de Rios, Stanley Krippner, Christel Lukoff, Dennis McKenna, Terence McKenna, Ralph Metzner, Donald Rothberg and Ilene Serlin for their valuable comments on earlier drafts of this article. Copyright © 1990 Transpersonal Institute The Journal of Transpersonal Psychology. 1990, Vol. 22, No.2 107 themselves transpersonal psychologists. As Vaughan (1984) has noted, "The transpersonal perspective is a meta-perspec­ tive, an attempt to learn from all different disciplines . emerging from the needed integration of ancient wisdom and modern science.
    [Show full text]
  • Eb07 REBIRTH-1.Pdf
    REBIRTH: The Psychedelic Movement Comes Of Age In the End I was cast out of the alchemists’ den, a lost mystic exile from the beats, wandering the naked streets of Basel at dawn and transmitting a lovely fix. I was high on acid, a green tab of Hofmann’s bicycle wheel I had rever- ently acquired from the Californian High Priest nights before, high in the hotel room overlooking the tram depot opposite the Basel Congress Centre. Site of the conference diabolique with Dr. Albert Hofmann, the 100 year old Alche- mist that birthed LSD - the ‘Problem Child’ that switched on the world. Now: cloudbanks are/ rolling/ blooming/ shifting overhead and as they open up and become for me everything else is doing the same – trees, cars, people - especially people. These beautiful marionette citizens of Basel, heading off to work, rugged up against the winter chill. They are polite, cool, efficiently progressing through the basic programs of larval life. Light glistens past a woman on the second floor balcony of an apartment block as she shakes out a blanket. Down below, surrounded by layers of white, white snow, a middle-aged man is walking his dog. He waits patiently, well trained, as it sniffs a pole. They are radiating energy signatures that overlap like kaleidoscope pictures and sink deep into me. You know this feeling, the current. A stream of energy is bubbling within you straight from the source, and the more you let go and let it rise up and blossom in/ from you, the deeper in you go.
    [Show full text]
  • Psychedelic Gospels
    The Psychedelic Gospels The Psychedelic Gospels The Secret History of Hallucinogens in Christianity Jerry B. Brown, Ph.D., and Julie M. Brown, M.A. Park Street Press Rochester, Vermont • Toronto, Canada Park Street Press One Park Street Rochester, Vermont 05767 www.ParkStPress.com Park Street Press is a division of Inner Traditions International Copyright © 2016 by Jerry B. Brown and Julie M. Brown All rights reserved. No part of this book may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the publisher. Note to the Reader: The information provided in this book is for educational, historical, and cultural interest only and should not be construed in any way as advocacy for the use of hallucinogens. Neither the authors nor the publishers assume any responsibility for physical, psychological, legal, or any other consequences arising from these substances. Library of Congress Cataloging-in-Publication Data [cip to come] Printed and bound in XXXXX 10 9 8 7 6 5 4 3 2 1 Text design and layout by Priscilla Baker This book was typeset in Garamond Premier Pro with Albertus and Myriad Pro used as display typefaces All Bible quotations are from the King James Bible Online. A portion of proceeds from the sale of this book will support the Multidisciplinary Association for Psychedelic Studies (MAPS). Founded in 1986, MAPS is a 501(c)(3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
    [Show full text]
  • Interview with Albert Hofmann by Michael Horowitz, 1976
    Inter-vie~ By Michael Horowitz ALBERT HOFMANN At the height of World War II, four months after the rapidly among the United States military and first artificially created nuclear reaction was re­ domestic security interests. By the middle 1950s, leased in a pile of uranium ore in Chicago, an LSD was being researched as a creativity enhancer accidentally absorbed trace of a seminatural rye and learning stimulant; rumors of its ecstatic, fungus product quietly exploded in the brain of a mystic and psychic qualities began to leak out 37-year-old Swiss chemist working at the Sandoz through the writings of Aldous Huxley, Robert research laboratories in Graves and other literary Basel. He reported to his Preliminary Note luminaries. supervisor: "I was forced A large-scale, non­ to stop I was at first not in agreement with the idea of my work in the publishing this interview here. I was surprjsed medical experiment in­ laboratory in the middle and shocked at the existence of such a magazine, volving LSD and other of the afternoon and to go whose text and advertising tended to treat the psychedelic drugs at home, as I was seized by subject of illegal druVS with a casual and non­ responsible attitude. Also, the manner in which Harvard in the early Six­ a peculiar restlessness High Times treats marijuana policy, which ties precipitated a fierce associated with a sensa­ urgently needs a solution, does not correspond to controversy over the lim­ my approach. tion of mild dizziness ... Nevertheless, I came to the deci­ its of sion that my statement's appearing in a magazine academic freedom a kind of drunkenness directed to readers who use currently illegal and focused national at­ which was not unpleas­ drugs might be of special value and could help to tention on the drug now ant and which was char­ diminish the abuse or misuse of the psychedelic known as "acid." Mid­ acterized by extreme ac­ drugs.
    [Show full text]
  • Psychedelia, the Summer of Love, & Monterey-The Rock Culture of 1967
    Trinity College Trinity College Digital Repository Senior Theses and Projects Student Scholarship Spring 2012 Psychedelia, the Summer of Love, & Monterey-The Rock Culture of 1967 James M. Maynard Trinity College, [email protected] Follow this and additional works at: https://digitalrepository.trincoll.edu/theses Part of the American Film Studies Commons, American Literature Commons, and the American Popular Culture Commons Recommended Citation Maynard, James M., "Psychedelia, the Summer of Love, & Monterey-The Rock Culture of 1967". Senior Theses, Trinity College, Hartford, CT 2012. Trinity College Digital Repository, https://digitalrepository.trincoll.edu/theses/170 Psychedelia, the Summer of Love, & Monterey-The Rock Culture of 1967 Jamie Maynard American Studies Program Senior Thesis Advisor: Louis P. Masur Spring 2012 1 Table of Contents Introduction..…………………………………………………………………………………4 Chapter One: Developing the niche for rock culture & Monterey as a “savior” of Avant- Garde ideals…………………………………………………………………………………...7 Chapter Two: Building the rock “umbrella” & the “Hippie Aesthetic”……………………24 Chapter Three: The Yin & Yang of early hippie rock & culture—developing the San Francisco rock scene…………………………………………………………………………53 Chapter Four: The British sound, acid rock “unpacked” & the countercultural Mecca of Haight-Ashbury………………………………………………………………………………71 Chapter Five: From whisperings of a revolution to a revolution of 100,000 strong— Monterey Pop………………………………………………………………………………...97 Conclusion: The legacy of rock-culture in 1967 and onward……………………………...123 Bibliography……………………………………………………………………………….128 Acknowledgements………………………………………………………………………..131 2 For Louis P. Masur and Scott Gac- The best music is essentially there to provide you something to face the world with -The Boss 3 Introduction: “Music is prophetic. It has always been in its essence a herald of times to come. Music is more than an object of study: it is a way of perceiving the world.
    [Show full text]
  • Albert Hofmann's Pioneering Work on Ergot Alkaloids and Its Impact On
    BIRTHDAY 83 CHIMIA 2006, 60, No. 1/2 Chimia 60 (2006) 83–87 © Schweizerische Chemische Gesellschaft ISSN 0009–4293 Albert Hofmann’s Pioneering Work on Ergot Alkaloids and Its Impact on the Search of Novel Drugs at Sandoz, a Predecessor Company of Novartis Dedicated to Dr. Albert Hofmann on the occasion of his 100th birthday Rudolf K.A. Giger* and Günter Engela Abstract: The scientific research on ergot alkaloids is fundamentally related to the work of Dr. Albert Hofmann, who was able to produce, from 1935 onwards, a number of novel and valuable drugs, some of which are still in use today. The complex chemical structures of ergot peptide alkaloids and their pluripotent pharmacological activity were a great challenge for Dr. Hofmann and his associates who sought to unravel the secrets of the ergot peptide alkaloids; a source of inspiration for the design of novel, selective and valuable medicines. Keywords: Aminocyclole · Bromocriptine Parlodel® · Dihydroergotamine Dihydergot® · Dihydro ergot peptide alkaloids · Ergobasin/ergometrin · Ergocornine · Ergocristine · α- and β-Ergocryptine · Ergolene · Ergoline · Ergoloid mesylate Hydergine® · Ergotamine Gynergen® · Ergotoxine · Lisuride · Lysergic acid diethylamide LSD · Methylergometrine Methergine® · Methysergide Deseril® · Paspalic acid · Pindolol Visken® · Psilocybin · Serotonin · Tegaserod Zelmac®/Zelnorm® · Tropisetron Navoban® Fig. 1. Albert Hofmann in 1943, 1979 and 2001 (Photos in 2001 taken by J. Zadrobilek and P. Schmetz) Dr. Albert Hofmann (Fig. 1), born on From the ‘Ergot Poison’ to *Correspondence: Dr. R.K.A. Giger January 11, 1906, started his extremely Ergotamine Novartis Pharma AG NIBR Global Discovery Chemistry successful career in 1929 at Sandoz Phar- Lead Synthesis & Chemogenetics ma in the chemical department directed The scientific research on ergot alka- WSJ-507.5.51 by Prof.
    [Show full text]
  • US Censors LSD Trial, Double Life Sentence Without Parole
    FACT exposé : US censors LSD trial, double life sentence without parole The Strange Trip and Fall of Leonard Pickard Criminal Injustice in the Heartland CJ Hinke [email protected] Freedom Against Censorship Thailand (FACT) http://facthai.wordpress.com More than 13 million Americans have tried LSD. US President John F. Kennedy himself engaged in LSD sessions with his lover Mary Pinchot with acid supplied by Timothy Leary. His brother, US Attorney General Robert F. Kennedy, was a vocal critic of the LSD ban; his wife, Ethel, was successfully treated for alcoholism in LSD sessions at Vancouver’s Hollywood Hospital, under the auspices of the International Association for Psychedelic Therapy, which claimed a success rate of 80%. Both brothers were assassinated; few know that Pinchot was also assassinated in her Washington apartment in 1964; her address book was never found. This article addresses another kind of assassination, life sentences for LSD. Nike Atlas Minuteman ICBM The heartland of the United States is riddled with hundreds of nuclear missile silos, now relics of the cold war. Many of these 20+ acre properties were sold to individuals including those doomsday proponents who saw them as the perfect place for survival come Armageddon. The silos have 47-ton fortified blast doors and a 66,000-pound battery bank. They also seem to be popular as a great modern location for server farms and hacker camps. Wamego, Kansas, is the heart of the heartland and welcomed the silos for their government employment opportunities in the country’s farm belt. Waumego was named after Potawatomie chief Waumego but all the Potawatomies were killed in the American Indian Wars in frontier massacres during the mid-1800s.
    [Show full text]
  • The Long, Strange Trip of Mescaline
    BOOKS & ARTS COMMENT harmacologists gave mescaline a fair trial. In Pthe early and mid- twentieth century, it seemed more than plausible that the fash- ionable hallucinogen could be tamed into a therapeutic agent. Mescaline: A After all, it had pro- Global History found effects on the of the First human body, and had Psychedelic been used for cen- MIKE JAY turies in parts of the Yale University Press Americas as a gateway (2019) to ceremonial spiritual experience. But this psychoactive alkaloid never found its clinical indication, as science writer Mike Jay explains in Mescaline, his anthropologi- cal and medical history. In the 1950s, the attention of biomedical researchers abruptly switched to a newly synthesized molecule with similar hallucinogenic properties but fewer physical side effects: lysergic acid di ethylamide, or LSD. First synthesized by Swiss scientist Albert Hofmann in 1938, LSD went on to become a recreational drug of choice in the 1960s hippy era. And, like mescaline, it teased psychiatrists without delivering a cure. ANCIENT HISTORY Jay traces the chronology of mescaline use. The alkaloid is found in the fast-growing San Pedro cactus (Echinopsis pachanoi) that towers above the mountainous desert scrub of the Andes, and the slow-growing, ground-hugging peyote cactus (Lophophora williamsii) native to Mexico and the south- western United States. Archaeological evidence suggests that the use of these cacti in rites of long-vanished cultures goes back at least 5,000 years. Europeans first came across peyote after Spain conquered Mexico in the early six- teenth century. (It is mentioned, for instance, in a mammoth study, The General History of the Things of New Spain, begun by scholar and friar Bernardino de Sahagún in 1529.) Attempts, largely by missionaries, to suppress WISEMAN ADAM Peyote cacti at a plant nursery in Mexico.
    [Show full text]
  • Mini Review on Psychedelic Drugs: Illumination on the Hidden Aspects of Mind
    Review Article Mini Review on Psychedelic Drugs: Illumination on the Hidden Aspects of Mind Lemlem Hussien Salih and Atul Kaushik* Department of Medicinal Chemistry, School of Pharmacy, Asmara College of Health Sciences, Asmara, Eritrea ABSTRACT Psychedelics constitute a class of psychoactive drugs with unique effects on consciousness. Psychedelic means mind/soul "revealing" and refers to the ability of these drugs to illuminate normally hidden aspects of mind or psyche. Many psychedelic agents occur in nature; others are synthetically produced. Naturally occurring psychedelic drugs have been inhaled, ingested, worshiped, and reviled since Address for prehistory. The phenomenology of the hallucinogenic experience is Correspondence extremely complex, sensory, emotional, cognitive, and spiritual, levels. Most psychedelic drugs structurally resemble with Department of neurotransmitters: acetylcholine, two catecholamines (nor Medicinal Chemistry, epinephrine and dopamine), and serotonin. These structural School of Pharmacy, similarities lead to three classes for categorizing psychedelic drugs: Asmara College of anticholinergic, catecholamine-like, and serotonin-like. And also a Health Sciences, fourth class of psychedelic drugs can be included, the psychedelic Asmara, Eritrea anesthetics. This mini review focuses on pharmacological and Tel.- +291-1-186041 medicinal aspects of this class. E-mail: atul_kaushik29 Keywords: Psychedelic drugs, Pharmacological features of @rediffmail.com psychedelic drugs, SAR of psychedelic drugs. INTRODUCTION "Rational consciousness...is but one produced. Naturally occurring psychedelic special type of consciousness, whilst all drugs have been inhaled, ingested, about it, parted from it by the filmiest of worshiped, and reviled since prehistory. screens; there lie potential forms of Native American shamans consumed consciousness entirely different."-William psychedelic plants such as the peyote cactus James.
    [Show full text]
  • A Social and Cultural History of the Federal Prohibition of Psilocybin
    A SOCIAL AND CULTURAL HISTORY OF THE FEDERAL PROHIBITION OF PSILOCYBIN A Dissertation presented to the Faculty of the Graduate School at the University of Missouri-Columbia In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy by COLIN WARK Dr. John F. Galliher, Dissertation Supervisor AUGUST 2007 The undersigned, appointed by the dean of the Graduate School, have examined the dissertation entitled A SOCIAL AND CULTURAL HISTORY OF THE FEDERAL PROHIBITION OF PSILOCYBIN presented by Colin Wark, a candidate for the degree of doctor of philosophy and hereby certify that, in their opinion, it is worthy of acceptance. Professor John F. Galliher Professor Wayne H. Brekhus Professor Jaber F. Gubrium Professor Victoria Johnson Professor Theodore Koditschek ACKNOWLEDGEMENTS The author would like to thank a group of people that includes J. Kenneth Benson, Wayne Brekhus, Deborah Cohen, John F. Galliher, Jay Gubrium, Victoria Johnson, Theodore Koditschek, Clarence Lo, Kyle Miller, Ibitola Pearce, Diane Rodgers, Paul Sturgis and Dieter Ullrich. ii TABLE OF CONTENTS ACKNOWLEDGEMENTS ................................................................................................ ii NOTE ON TERMINOLOGY ............................................................................................ iv Chapter 1. INTRODUCTION…………………………………………………………………1 2. BIOGRAPHICAL OVERVIEW OF THE LIVES OF TIMOTHY LEARY AND RICHARDALPERT…………………………………………………….……….20 3. MASS MEDIA COVERAGE OF PSILOCYBIN AS WELL AS THE LIVES OF RICHARD ALPERT AND TIMOTHY
    [Show full text]
  • Horizons, the Fifth Annual Conference on Psychedelic Research
    4SYMPOSIUM REPORT The Psychedelic Renaissance: Horizons, the Fifth Annual Conference on Psychedelic Research Michael Cooper, BA Albert Einstein College of Medicine, Bronx, NY 10461. INTRODUCTION projects from experts in the psychedelics field. The top- ics of that year’s conference ranged from the treatment In the spring of 1943, a 37-year-old Swiss chemist named of post-traumatic stress disorder (PTSD) with the use of Albert Hofmann had “a peculiar presentiment.” He 3,4-methylenedioxymethamphetamine (MDMA) to the believed that he had missed something in 1938, the year use of psilocybin as a treatment for depression and anxi- when he first synthesized the twenty-fifth compound of ety in terminal cancer patients. the lysergic acid diethylamide series, LSD-25. For eight years at Sandoz Pharmaceuticals, Hofmann was in charge SELECTED CONFERENCE PRESENTATIONS of the ergot project, which involved synthesizing ergota- mine molecules for the treatment of migraines. On April MAPS’ International Psychedelic Clinical Research: The 16, 1943, guided by a premonition, Hofmann synthesized Past, Present, and Future, by Berra Yazar-Klosinski, PhD and ingested a crystalline water-soluble batch of LSD- 25. Shortly thereafter, Hofmann experienced “an unin- Berra Yazar-Klosinski, a clinical research associate at terrupted stream of fantastic images of extraordinary MAPS, provided an overview of the history of MDMA plasticity and vividness . accompanied by an intense before describing two clinical research projects investi- kaleidoscopic play of colors” (Stevens, 1987). gating potential therapeutic properties of the drug. In 1912, Merck & Co., Inc., first synthesized MDMA, com- Less than thirty years after Hofman’s discovery, the monly referred to as ecstasy, as a blood-clotting agent.
    [Show full text]
  • Chemical Salvation?
    CHEMICAL ✩ SALVATION? J.C.T. April 16, 1943 While recrystallizing to purify the chemical, Basel, Switzerland Dr. Hofmann becomes restless and dizzy. rick LLC. Printed in U.S.A. Sandoz Laboratories chemist Dr. Albert Hofmann resynthesizes a compound he’d created five years earlier: lysergic acid diethylamide-25. © 2006 by Jack C. T Back at his lab, Dr. Hofmann decides to perform a self-experiment with the drug. Hmm… there’s a kaleidoscope of images in my mind… He sinks into an inebriated dream-like state, Based on the known activity which fades after two hours. Three days later, of other ergot alkaloids, he wonders if accidental absorption of the the smallest dose… LSD might have caused his mental condition. …that should have any effect is 0.25 milligrams.* * That’s 250 micrograms, or approximately ten times a minimally active dose! About 40 minutes after ingesting the drug, Dr. Hofmann is again stricken by dizziness. He heads home on his bicycle. Sss… some… milk… please… Once at home, he has trouble speaking intelligibly. The world is utterly transformed. A neighbor lady who brings him milk becomes a malevolent witch. But slowly, Dr. Hofmann’s fear-based experience changes into a more enjoyable display of colorful, flowing mental imagery. Am I… dying?* * The sense of experiencing one’s own death is sometimes reported as a mystical component of an LSD voyage. Others at the Sandoz lab later confirm the activity of LSD. At one-third of the dose that Dr. Hofmann had taken, they still had profound effects. Es gefällt mir.
    [Show full text]